ย 

๐— ๐—ผ๐—ป๐˜๐—ต๐—น๐˜† ๐—ฆ๐˜๐—ฎ๐˜๐—ฒ๐—บ๐—ฒ๐—ป๐˜: ๐‰๐ฎ๐ง๐ž ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿญ

๐ŸŸข ๐Ÿ‘.๐Ÿ%: ๐—›๐—ถ๐—ด๐—ต๐—ฒ๐˜€๐˜ ๐—ฑ๐—ฎ๐—ถ๐—น๐˜† ๐—ฝ๐—ฒ๐—ฟ๐—ณ๐—ผ๐—ฟ๐—บ๐—ฎ๐—ป๐—ฐ๐—ฒ

๐ŸŸข ๐Ÿ’.๐Ÿ—%: ๐— ๐—ผ๐—ป๐˜๐—ต๐—น๐˜† ๐—ฝ๐—ฒ๐—ฟ๐—ณ๐—ผ๐—ฟ๐—บ๐—ฎ๐—ป๐—ฐ๐—ฒ

๐ŸŸข ๐Ÿ”๐Ÿ“.๐Ÿ”๐Ÿ‘%: ๐Ÿ๐Ÿ-๐ฆ๐จ๐ง๐ญ๐ก๐ฌ ๐ซ๐ž๐ญ๐ฎ๐ซ๐ง


๐…๐ข๐ซ๐ฌ๐ญ ๐จ๐Ÿ ๐š๐ฅ๐ฅ, ๐ˆ ๐ฐ๐š๐ซ๐ฆ๐ฅ๐ฒ ๐ฐ๐ž๐ฅ๐œ๐จ๐ฆ๐ž ๐š๐ฅ๐ฅ ๐ง๐ž๐ฐ ๐œ๐จ๐ฉ๐ข๐ž๐ซ๐ฌ ๐š๐ง๐ ๐Ÿ๐จ๐ฅ๐ฅ๐จ๐ฐ๐ž๐ซ๐ฌ. ๐“๐ก๐š๐ง๐ค ๐ฒ๐จ๐ฎ ๐Ÿ๐จ๐ซ ๐ฒ๐จ๐ฎ๐ซ ๐ญ๐ซ๐ฎ๐ฌ๐ญ! ๐˜๐จ๐ฎ ๐ฆ๐š๐๐ž ๐ญ๐ก๐ž ๐ซ๐ข๐ ๐ก๐ญ ๐œ๐ก๐จ๐ข๐œ๐ž ๐š๐ง๐ ๐ก๐š๐ฏ๐ž ๐œ๐จ๐ฆ๐ž ๐ญ๐จ ๐ญ๐ก๐ž ๐ซ๐ข๐ ๐ก๐ญ ๐ฉ๐ฅ๐š๐œ๐ž.


๐ˆ๐ง ๐š๐๐๐ข๐ญ๐ข๐จ๐ง, ๐ˆ ๐œ๐š๐ง ๐š๐ง๐ง๐จ๐ฎ๐ง๐œ๐ž ๐ญ๐ก๐š๐ญ ๐ˆ ๐ก๐š๐ฏ๐ž ๐ง๐จ๐ญ ๐จ๐ง๐ฅ๐ฒ ๐ฉ๐š๐ฌ๐ฌ๐ž๐ ๐ญ๐ก๐ž $๐Ÿ“๐ŸŽ,๐ŸŽ๐ŸŽ๐ŸŽ ๐ฆ๐š๐ซ๐ค ๐ข๐ง ๐š๐ฌ๐ฌ๐ž๐ญ๐ฌ ๐ฎ๐ง๐๐ž๐ซ ๐ฆ๐š๐ง๐š๐ ๐ž๐ฆ๐ž๐ง๐ญ (๐€๐”๐Œ), ๐›๐ฎ๐ญ ๐š๐ฅ๐ฌ๐จ ๐ญ๐ก๐ž $๐Ÿ๐ŸŽ๐ŸŽ,๐ŸŽ๐ŸŽ๐ŸŽ ๐ฆ๐š๐ซ๐ค. ๐“๐ก๐ข๐ฌ ๐ข๐ฌ ๐š ๐ ๐ซ๐ž๐š๐ญ ๐ฆ๐ข๐ฅ๐ž๐ฌ๐ญ๐จ๐ง๐ž ๐š๐ง๐ ๐ฆ๐š๐ค๐ž๐ฌ ๐ฆ๐ž ๐ฏ๐ž๐ซ๐ฒ ๐ก๐š๐ฉ๐ฉ๐ฒ ๐š๐ง๐ ๐ฉ๐ซ๐จ๐ฎ๐. ๐€๐ฌ ๐š ๐ซ๐ž๐ฌ๐ฎ๐ฅ๐ญ ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐š๐œ๐œ๐จ๐ฆ๐ฉ๐ฅ๐ข๐ฌ๐ก๐ฆ๐ž๐ง๐ญ, ๐ˆ ๐š๐ฆ ๐ง๐จ๐ฐ ๐š ๐๐จ๐ฉ๐ฎ๐ฅ๐š๐ซ ๐ˆ๐ง๐ฏ๐ž๐ฌ๐ญ๐จ๐ซ ๐จ๐Ÿ ๐ญ๐ก๐ž "๐‚๐ก๐š๐ฆ๐ฉ๐ข๐จ๐ง" ๐ฅ๐ž๐ฏ๐ž๐ฅ.


After the turbulence in May, June was a lot calmer. Overall, some portfolio positions rose sharply. Among them were $NTLA (Intellia Therapeutics Inc) and $ETSY (Etsy Inc) . Intellia thereby with over 180% due to a truly significant breakthrough: based on Crispr-tech-gene-editing (en.wikipedia.org/wiki/CRISPR_gene_editing), they were able to successfully treat an internal organ externally for first time (see more here: on.ft.com/3vY2WAb)


Also, I have been able to take advantage of some price declines for additions to the portfolio: $CMI (Cummins Inc (Ex. Cummins Engine Inc))$VXX (as hedge) $ETSY$PSLV$ETH


If you have any questions, feel free to check out my website and the FAQ page there or write to me directly. I try to answer every request.


BR


www.oboi-invest.com/

ย 
>
    
    <script type=